Lisa Speer, NP
Medical Advisory Board – Skydell Medical
Advancing compliant regenerative medicine through clinical implementation, operational strategy, and policy leadership.
Co-author of the Florida stem cell legislation • Nurse Practitioner • Award-winning healthcare strategist
About Lisa Speer
Lisa Speer, NP, is an experienced Nurse Practitioner and award-winning healthcare strategist recognized for her leadership in operational scaling and clinical implementation within regenerative and advanced medical practices. She has played a key role in shaping compliant stem cell policy in the state of Florida as a co-author of the state’s stem cell legislation, supporting the responsible and ethical advancement of regenerative medicine.
With a strong focus on translating innovation into real-world clinical success, Lisa works at the intersection of patient care, practice optimization, and regulatory alignment. Her expertise helps medical organizations implement new therapies efficiently while maintaining the highest standards of safety, compliance, and outcomes.
Her approach combines clinical insight with systems-level strategy — enabling providers to scale sustainably, improve workflow performance, and deliver consistent, high-quality patient experiences.
Her Role at Skydell Medical
As a member of the Medical Advisory Board, Lisa Speer contributes strategic and clinical guidance in:
- Clinical implementation of regenerative medicine protocols
- Operational scaling for multi-provider practices
- Compliance-focused program development
- Workflow optimization and care delivery models
- Provider training and adoption of new therapies
Her leadership supports Skydell Medical’s mission to build a standardized, scalable, and compliant regenerative medicine ecosystem.
Clinical & Strategic Expertise
- Regenerative medicine program implementation
- Practice operations and performance scaling
- Clinical workflow design
- Patient-centered care models
- Policy and regulatory alignment
- Provider education and training systems
Leadership & Industry Impact
As a co-author of Florida’s stem cell legislation, Lisa has helped establish a framework that enables innovation while protecting patients and providers through clear clinical and regulatory standards. Her work bridges the gap between emerging medical technologies and day-to-day clinical practice, ensuring that advancements are both accessible and responsibly delivered.
Her award-winning strategic leadership has supported healthcare organizations in achieving measurable growth, improved efficiency, and long-term sustainability.